| Pre-treatment | Post-treatment | 6 month follow-up | 12 month follow-up | ||||
---|---|---|---|---|---|---|---|---|
G | W | G | W | G | W | G | W | |
CSR | 5.50 (1.11) | 5.56 (1.33) | 2.17 (2.56) | 2.52 (2.54) | 0.48 (1.48) | 1.52 (2.55) | 0.92 (2.14) | 1.15 (2.46) |
SCAS-P | 34.28 (12.60) | 32.70 (14.52) | 21.58 (9.83) | 27.92 (12.26) | 21.39 (7.06) | 24.52 (10.78) | 21.11 (10.10) | 23.03 (14.65) |
SCAS-C | 28.44 (19.45) | 32.18 (16.76) | 27.99 (15.02) | 30.69 (19.55) | 23.33 (14.89) | 26.34 (16.51) | 22.68 (22.02) | 22.63 (19.50) |
CGI | – | – | 2.14 (0.94) | 2.89 (1.03) | 1.87 (0.87) | 2.09 (1.20) | 2.18 (1.25) | 1.84 (1.05) |
PSS | – | – | 62.75 (5.55) | 63.01 (6.27) | – | – | – | – |
FAD | 1.79 (0.48) | 1.76 (0.41) | 1.81 (0.47) | 1.79 (0.48) | 1.78 (0.46) | 1.77 (0.53) | 1.67 (0.51) | 1.63 (0.48) |
SCAS-P (Sibling) | 17.59 (11.96) | 19.53 (9.42) | – | – | 11.85 (4.13) | 13.60 (5.95) | 9.93 (4.20) | 11.85 (4.61) |
DASS-S | 6.12 (3.79) | 7.29 (4.53) | 5.83 (5.76) | 6.42 (6.33) | 5.84 (7.04) | 6.51 (7.80) | 5.83 (11.67) | 7.35 (13.18) |
DASS-A | 1.73 (2.65) | 2.53 (3.06) | 1.10 (2.22) | 1.56 (2.56) | 0.96 (2.75) | 1.76 (3.48) | 0.84 (8.40) | 0.92 (9.34) |